Donggucefixim Hydrate Capsule 100 Milligrams

Adult dose

Adults: Administer 50～100mg (potency) of cefixime hydrate per dose orally 2 times daily. For severe cases or when the effect is insufficient, administer 200mg (potency) per dose 2 times daily. Adjust the dose appropriately according to age and symptoms.

Child dose

Children weighing 30 Kg or more: Administer 50～100mg (potency) of cefixime hydrate per dose orally 2 times daily. For severe cases or when the effect is insufficient, administer 200mg (potency) per dose 2 times daily.

This medication should not be administered to certain patients. For example, patients who have previously experienced shock due to this medication or are allergic to cephalosporin antibiotics should not take it. Additionally, this medication contains lactose, so patients with genetic lactose intolerance or related conditions should avoid it. Caution is necessary when administering this medication. Patients who have had allergic reactions to this medication or to cefem antibiotics should preferably not use it, and if it must be used, they should be carefully monitored. Patients allergic to penicillin-based antibiotics or those with a tendency to easily exhibit allergic symptoms such as asthma, skin rashes, and urticaria should also exercise caution. Patients with severely impaired kidney function may experience increased concentration of this medication, so dosage adjustments and dosing intervals are required. Patients unable to take orally, those receiving non-oral nutrition, elderly patients, and those with poor general condition may exhibit vitamin K deficiency symptoms, so their condition should be closely monitored. This medication contains Yellow No. 5 dye, so patients allergic to this component should be cautious. Rare side effects may include shock, anaphylaxis, skin rash, gastrointestinal disturbances, respiratory issues, blood abnormalities, central nervous system disturbances, etc., so if symptoms occur, discontinue use immediately and consult a healthcare professional. In particular, if severe diarrhea such as pseudomembranous colitis occurs, medication should be stopped immediately. Regular testing is necessary as liver or kidney function may be affected, and if any abnormal signs are detected, discontinuation of administration is required. Moreover, this medication may inhibit the production of vitamin K by intestinal bacteria, thus increasing the risk of bleeding when taken in conjunction with warfarin, so caution is needed. Additionally, the co-administration of this medication with certain drugs may increase renal toxicity, so patients must inform healthcare providers of any other medications they are taking. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of taking this medication, and it is recommended to avoid breastfeeding during the treatment period. Safety for newborns, premature infants, and infants under 6 months has not been established, so it is preferable not to use this medication in these groups. Elderly patients often have decreased bodily functions, making them more susceptible to side effects, so dosage and administration intervals should be adjusted, and their condition closely monitored. This medication may also influence some clinical test results, so caution is required in interpreting test results. Finally, the suspension of this medication should not be stored for more than two weeks after manufacturing, and powder forms should not be mixed with milk or juice for prolonged periods.

shock, discomfort, oral dysesthesia, wheezing, dizziness, stool issues, tinnitus, sweating, anaphylactic symptoms, shortness of breath, generalized flushing, edema, urticaria, rash, erythema, itching, fever, erythema multiforme, serum sickness-like reaction, abdominal pain, leukocytosis, severe diarrhea accompanied by mucus and bloody stools, pseudomembranous colitis, vomiting, diarrhea, epigastric discomfort, heartburn, loss of appetite, nausea, abdominal bloating, constipation, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, eosinophilic lung infiltration, granulocytopenia, hemolytic anemia, thrombocytopenia, agranulocytosis, prolonged prothrombin time, seizures, toxic epidermal necrolysis, Stevens-Johnson syndrome, liver dysfunction, jaundice, acute renal failure, stomatitis, candidiasis, vitamin K deficiency symptoms, hypoprothrombinemia, bleeding tendency, vitamin B group deficiency symptoms, glossitis, neuritis, headache, anxiety, genital itching, vaginitis

This medication should be stored in a tightly sealed container to prevent air exposure, preferably at a temperature between 1 and 30 degrees Celsius. This helps maintain the efficiency of the drug and prevent deterioration.

Appearance

Light orange hard capsule filled with crystalline powder that is white to light yellow.

Package unit

30 capsules/bottle, 100 capsules/bottle